Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05764538 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DAOIB for the Treatment of Brain Fog

StatusRecruiting
PhasePhase 2
Started2023-02-27
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 19, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-03-18
Study Status v2
Primary completion date2025-02→2026-06
Completion date2025-02→2026-06
2024-06-16
Study Status v1
Re-verified, no change to tracked fields
2023-02-28
Original filing
This is a 24-week open trial. We will enroll long-COVID patients with cognitive impairments. All patients will receive DAOIB for 24 weeks. We will assess the patients every 8 weeks during the treatment period (weeks 0, 8, 16, and 24). We hypothesize that DAOIB treatment will be beneficial in improving the cognitive function, mood symptoms, global functioning and quality of life in long-COVID patients with cognitive impairments.
Trial Details
NCT Number NCT05764538
Lead Sponsor Chang Gung Memorial Hospital
Conditions Long COVID
Enrollment 40 participants
Start Date 2023-02-27
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-19